Britain's MS Society and the research organization Medical Research Council Technology have partnered to identify and develop new drugs for treating multiple sclerosis. The society will fund academic research programs over a two-year period, which will then be evaluated by MRC Technology for use in small-molecule and antibody projects that could lead to new MS therapies.

Full Story:
PharmaTimes (U.K.)

Related Summaries